PRGF Therapy (Plasma Rich in Growth Factors)

Refined, leukocyte‑poor plasma that delivers sustained, gentle healing for acute injuries and post‑surgical repair.

Leukocyte‑poor (>95% removed)

Reduced soreness & swelling

Sustained release 2–3 weeks

Ideal for acute/sensitive tissues

Book a consultation
How MSCs Work

What is PRGF Therapy?

PRGF uses concentrated healing proteins from your blood to accelerate repair. Unlike standard PRP, PRGF undergoes additional refinement to eliminate inflammatory white blood cells while preserving growth factors, resulting in controlled, sustained healing with minimal inflammatory response.

Clinical evidence demonstrates accelerated recovery and improved outcomes, particularly for acute injuries and post‑surgical applications.

Core advantages

  • Leukocyte‑poor: >95% WBC removed
  • Sustained growth factor release: 2–3 weeks
  • Gentler response for acute/sensitive tissues

Delivery: ultrasound‑guided injection with fibrin matrix forming a biological scaffold for protection and gradual release.

Common Applications

Best for acute injuries, post‑surgical healing, or chronic conditions where inflammatory response must be minimized.

Acute sports injuries

Gentle, sustained stimulus with minimal inflammation for sensitive tissues.

  • Fresh muscle tears
  • Ligament sprains
  • Acute tendon injuries (2–6 weeks)

Surgical augmentation

Enhances post‑op healing with controlled growth factor release.

 

  • Arthroscopic repairs
  • Ligament reconstructions

Subacute conditions

Bridges early recovery with steady biochemical support.

  • Healing phase 6–12 weeks
  • Requires gentle stimulation

Joint degeneration

Prolonged release aligns with cartilage repair timelines.

  • Grade 2–4 osteoarthritis

Fracture healing

Biologic scaffold supports bone repair and angiogenesis.

  • Non‑union
  • Delayed union (athletes)

Limitations of Standard Treatment

Conventional approaches have inherent constraints:

Standard PRP

Contains white blood cells triggering excessive inflammation in acute injuries - causing pain and swelling in sensitive tissues while delivering only 7-10 days of growth factor release.

Corticosteroids

Suppress essential inflammation and may compromise tissue repair in acute injuries and post-surgical healing.

RICE protocol alone

Manages symptoms without actively accelerating healing or improving tissue quality.

Why this matters

PRGF’s leukocyte-poor composition and sustained-release mechanism (2-3 weeks) provide gentler, longer-lasting stimulation – critical for optimal recovery in acute injuries and sensitive conditions.

BRC’s Regenerative Solutions

PRGF represents the next evolution in platelet therapy.

Leukocyte‑poor formulation:

  • Removes >95% of white blood cells, eliminating pro‑inflammatory mediators
  • Prevents excessive inflammation in acute injuries and sensitive tissues
  • Reduces post‑injection soreness and swelling

Sustained growth factor release:

  • Fibrin scaffold releases growth factors over 2–3 weeks (vs. 7–10 days with standard PRP)
  • Prolonged stimulus matches repair timelines
  • Particularly beneficial for tendon and ligament healing

Optimized growth factor profile:

  • Elevated TGF‑β1 promotes collagen organization and reduces scarring
  • Higher PDGF‑BB stimulates blood vessel formation
  • Balanced VEGF encourages controlled angiogenesis

Results in higher‑quality tissue repair vs. fibrous scar tissue

PRGF vs. other therapies

Similar platelet concentration to standard PRP (3–5×) but refined composition and sustained release make it preferable for acute/sensitive conditions; more practical than Growth Factor Concentrate for most orthopedic applications.

Delivery: ultrasound‑guided injection (joints) or IV infusion (systemic). Procedures 30–60 minutes; most resume normal activity in 24–48 hours.

Treatment Process & Expected Outcomes

Blood draw & refine

Specialized centrifugation concentrates growth factors and removes inflammatory cells.

Ultrasound guidance

Precise placement into the affected tissue with minimal discomfort.

Fibrin matrix forms

Creates a protective scaffold and slow‑release reservoir.

Total procedure time: ~15–20 minutes.

Acute injuries

  • Single injection often sufficient
  • Improvements in 1–2 weeks
  • 70–80% recovery by 6–8 weeks

Clinical improvements

  • Pain: VAS 6–8/10 → 2–3/1
  • Function: WOMAC +40–60%
  • Better tissue quality on imaging

Chronic conditions

  • 2–3 treatments, 3–4 weeks apart
  • Initial improvement at 2–3 weeks
  • Results sustain ~12–18 months

Post‑surgical

  • Single application at surgery or 2–4 weeks post‑op
  • Rehab timeline shorter by 20 - 30% (published studies)

Which Regenerative Option Fits Your Case?

Match condition type with the appropriate therapy.

PRGF

Choose PRGF when:

  • Acute injury (< 6 weeks) needing gentle stimulation
  • Post‑surgical healing with sustained support
  • Inflammatory sensitivity to standard PRP
  • Grade 2–4 osteoarthritis
  • Aim for higher tissue quality with less scarring

PRP

Choose PRP when:

  • Cost‑effective for chronic tendinopathy
  • Reduced insulin requirements
  • Localized issues with proven results

GF

Choose Growth Factor when:

  • Maximum power for complex wounds
  • Aesthetic rejuvenation or hair restoration
  • Unresponsive to standard PRP/PRGF

MSCs

Choose Stem Cell when:

  • Systemic conditions (diabetes, autoimmune, organ dysfunction)
  • Need cellular replacement + immune modulation

Tired of treatments that only provide temporary relief?

Our comprehensive consultation evaluates your condition and develops a personalized regenerative therapy plan.

Please bring: Recent imaging studies (X-rays, MRI, ultrasound), current medication list, and previous treatment history.

Online Booking Available